Immune checkpoint inhibitors (ICIs) are now used routinely to treat advanced or metastatic
urothelial and renal cell carcinoma, among other cancers. Furthermore, multiple trials are …

Cancer-related fatigue is one of the most common symptoms of cancer and one of those
referred by patients as the most disabling. However, we still do not have enough evidence to …

Cancer-related fatigue (CRF) is the most common side effect of cancer treatment. Regular
surveillance is recommended, but few clinical practice guidelines transparently assess study …

Purpose Cancer-related fatigue (CRF) is a debilitating symptom experienced by many
cancer patients. Although guidelines provide evidence-based recommendations for …

Context Cancer-related fatigue (CRF) is a distressing and persistent sense of tiredness or
exhaustion that interferes with usual functioning. Chronic CRF continues for months after …

Background Cancer-related fatigue (CRF) is a key concern for people living with cancer and
can impair physical functioning and activities of daily living. Evidence-based guidelines for …

Background Fatigue is a complex and frequent symptom in cancer patients, influencing their
quality of life, but it is still underestimated and undertreated in clinical practice. The aims of …

Objectives: To examine the adherence to and the usefulness, satisfaction, and preliminary
efficacy of a 12-week self-management energy conservation and active management …

Background Cancer-related fatigue (CRF) is the most reported side effect of cancer and its
treatments. This distressing sense of exhaustion critically impairs quality of life and can …

This study describes the prevalence and persistence of fatigue among a cohort of long-term
non-Hodgkin lymphoma (NHL) survivors. Mailed surveys assessed quality-of-life including …